1 Pediatric & Reproductive Endocrinology Branch, National Institutes of Health, Bethesda, MD 20892 and 2 Department of Obstetrics and Gynecology, Uniformed Services University of the Health Sciences, Bethesda, MD 20814, USA
3 To whom correspondence should be addressed at: NICHD, Pediatric & Reproductive Endocrinology Branch, Building 10, Room 9D-42, Bethesda, MD 20892, USA. e-mail: segarsj{at}mail.nih.gov
![]() |
Abstract |
---|
![]() ![]() ![]() ![]() ![]() ![]() |
---|
Key words: FSH deficiency/granulosa cell tumour/hypothalamic amenorrhoea/infertility/inhibin B
![]() |
Introduction |
---|
![]() ![]() ![]() ![]() ![]() ![]() |
---|
However, not all patients with serum levels consistent with isolated FSH deficiency have a mutation in the FSH chain. FSH and LH release is both positively and negatively affected by estrogen and progesterone, and at least three protein hormones secreted by the ovary: activin A, and inhibins A and B (Magoffin and Jakimiuk, 1997
; Lockwood et al., 1998
; Welt et al., 2002
). Inhibin B is secreted by granulosa cells and acts on the pituitary to directly suppress FSH production.
We report a woman with an inhibin B-secreting granulosa cell tumour that presented with infertility and values of circulating FSH consistent with isolated FSH deficiency. The finding of elevated inhibin B may be an invaluable test in the assessment of patients with apparent idiopathic hypogonadotrophic hypogonadism or functional hypothalamic amenorrhoea to alert the clinician of a possible ovarian tumour.
![]() |
Case report |
---|
![]() ![]() ![]() ![]() ![]() ![]() |
---|
Cycle day 3 blood sampling revealed FSH = 0.8 mIU/ml, LH = 6.7 mIU/ml and estradiol = 129 pg/ml (Table I). The patient was diagnosed with anovulation caused by PCOS, and was started on clomiphene citrate 50 mg/day on cycle days 59. No evidence of ovulation was seen with urinary LH or day 21 progesterone. The dose was increased to 100 mg/day and then to 150 mg/day, but the patient remained anovulatory. A clomiphene citrate challenge test (CCCT) was then performed, showing a 3-fold increase in LH levels, with practically no response in FSH (Table II).
|
|
|
|
|
![]() |
Discussion |
---|
![]() ![]() ![]() ![]() ![]() ![]() |
---|
Inhibin A and B are secreted by the granulosa cells of the ovary in response to FSH and play an essential role in the regulation of follicular development. The recent development of specific assays for inhibin A and inhibin B (Groome et al., 1996) have clarified their respective roles in follicular development (Welt et al., 2002
). Both inhibins suppress FSH levels, providing a negative feedback loop for FSH production (Groome et al., 1996
; Soules et al., 1998
; Welt et al., 2002
). Several studies have shown that serum levels of inhibin are elevated in patients with ovarian sex-cord stromal tumours and that secretion may not be dependent upon FSH stimulation (Lappohn et al., 1989
; Jobling et al., 1994
; Hildebrandt et al., 1997
; Risbridger et al., 2001
). Not only are granulosa cell tumours capable of secreting inhibin B as well as inhibin A (Petraglia et al., 1998
; Robertson et al., 1999
; Ala-Fossi et al., 2000
), but fibrothecomas and other ovarian tumours secrete biologically active inhibin molecules (Hildebrandt et al., 1997
; Burger et al., 2001
). It is worth noting that circulating inhibins in women with ovarian cancer are structurally similar, are of similar molecular weight (Robertson et al., 2002
), and in most cases function similarly to inhibins produced from normal ovarian tissue.
In their report of inhibin as a marker for granulosa cell tumours, Lappohn et al. (1989) described three women with infertility, elevated inhibin levels, and granulosa cell tumours. There are at least two detailed case reports of granulosa cell tumours that presented with secondary amenorrhoea and infertility associated with elevated inhibin levels (Sakamoto et al., 1998
; Hiroi et al., 2000
), although the association of granulosa cell tumours with infertility and secondary amenorrhoea has been described without mention of inhibin levels (Porestsky et al., 1988
; Willemsen et al., 1993
; Fox and Draycott, 1996
). Sakamoto et al. (1998
) reported a granulosa cell tumour in a 42 year old with low FSH (0.8 mIU/ml) and normal LH (17 mIU/ml), findings similar to our report. They also reported an elevated serum inhibin of 17 IU/ml (Sakamoto et al., 1998
), but in contrast with our report, inhibin A was detected in the tumour cells. Hiroi et al. (2000
) reported a patient with early menopause at age 44 years who was subsequently diagnosed with a granulosa cell tumour 4 years later. The patient was found to have suppressed FSH of <1.0 mIU/ml and an elevated inhibin of 218.7 IU/ml. After removal of the tumour, FSH and inhibin levels returned to the normal post-menopausal range. The tumour stained for inhibin, but the distinction between inhibin A and inhibin B was not reported.
Since inhibin B may be produced by ovarian tumours other than granulosa cell tumours (Flemming et al., 1996; Hildebrandt et al., 1997
; Petraglia et al., 1998
; Robertson et al., 1999
; Burger et al., 2001
), suppression of FSH, amenorrhoea and subsequent infertility may result from these tumours as well. There is one report of an ovarian fibrothecoma in a woman presenting with secondary amenorrhoea and infertility. Meyer et al. (2000
) reported a 37 year old female with LH = 22.7 mIU/ml, FSH <1.5 mIU/ml and estradiol of 26 pg/ml. Serum inhibin B was extremely high, at 1154 pg/ml. The fibrothecoma stained strongly for the inhibin
subunit.
The ability of ovarian tumours to cause infertility by secretion of FSH-suppressing hormones is relevant to the possible association of infertility medication, specifically clomiphene citrate, with ovarian tumours (Willemsen et al., 1993; Rossing et al., 1994
; Tarlatzis et al., 1995
). As in our patient, the diagnosis of an ovarian tumour may be established only after treatment with clomiphene citrate in an attempt to correct anovulation ultimately caused by the tumour itself. Our results lend support to the possibility that an existing ovarian tumour secreting inhibin must be taken into account in assessment and analysis of the association between infertility medication and ovarian tumours. This is an important consideration, since 71% of fibrothecomas, 60% of mucinous cystadenocarcinomas, and 18% of poorly differentiated ovarian carcinomas may secrete inhibins (Hildebrandt et al., 1997
; Robertson et al., 1999
; Burger et al., 2001
; Risbridger et al., 2001
). In support of a transient effect upon fertility caused by the tumour itself (rather than long-standing infertility attributable to another aetiology), in many instances reports have shown that a high rate of spontaneous pregnancy may follow removal of the ovarian tumour (Willemsen et al., 1993
; Salle et al., 1997
; Unkila-Kallio et al., 2000
), a point which we have also noted (Cisar et al., 2001
).
In summary, the value of measuring serum inhibin in the assessment of women with secondary amenorrhoea has not been emphasized. A subset of patients diagnosed with functional hypothalamic amenorrhoea may have occult ovarian tumours. Low FSH levels coupled with normal estradiol levels in a patient warrants further evaluation with inhibin B even in cases where ovaries appear normal on ultrasound. Elevated inhibin in this setting may alert the clinician to the presence of an unsuspected tumour.
![]() |
References |
---|
![]() ![]() ![]() ![]() ![]() ![]() |
---|
Burger, H.G., Fuller, P., Chu, S., Mamers, P., Drummond, A., Susil, B., Neva, P. and Robertson, D.M. (2001) The inhibins and ovarian cancer. Mol. Cell. Endocrinol., 180, 145148.[CrossRef][ISI][Medline]
Cisar, M., Rose, S., Reid, E., Murdock, C.M., Nieman, L. and Segars, J. (2001) Pseudo-isolated FSH deficiency caused by inhibin beta-secreting ovarian tumors: report of three cases. Fertil. Steril., 76, S164S165.
Flemming, P., Grothe, W., Maschek, H., Petry, K.U., Wellmann, A. and Georgh, A. (1996) The site of inhibin production in ovarian neoplasms. Histopathology, 29, 465468.[ISI][Medline]
Fox, R. and Draycott, T. (1996) Macrofolliculoid granulosa cell tumor mistaken for a polycystic ovary at ultrasound scan. Aust. NZ J. Obstet. Gynecol., 36, 492493.[ISI][Medline]
Groome, N.P., Illingworth, P.J., OBrien, M., Pai, R., Rodger, F.E., Mather, J.P. and McNeilly, A.S. (1996) Measurement of dimeric inhibin B throughout the human menstrual cycle. J. Clin. Endocrinol. Metab., 81, 14011405.[Abstract]
Hildebrandt, R.H., Rouse, R.V. and Longacre, T.A. (1997) Value of inhibin in the identification of granulosa cell tumors of the ovary. Hum. Pathol., 28, 13871395.[ISI][Medline]
Hiroi, H., Momoeda, M., Yamauchi, N., Abe, Y., Yoshikawa, H., Tsutsumi, O. and Taketani, Y. (2000) An earlier menopause as clinical manifestation of granulosa-cell tumor: a case report. J. Obstet. Gynecol. Res., 26, 912.
Jobling, T., Mamers, P., Healy, D.L., MacLachlan, V., Burger, H.G., Quinn, M., Rome, R. and Day, A.J. (1994) A prospective study of inhibin in granulosa cell tumors of the ovary. Gynecol. Oncol., 55, 285289.[CrossRef][ISI][Medline]
Lappohn, R.E., Burger, H.G., Bouma, J., Bangah, M., Krans, M. and de Bruijn, H.W.A. (1989) Inhibin as a marker for granulosa cell tumors. N. Engl. J. Med., 321, 790793.[Abstract]
Layman, L.C., Lee, E.-J., Peak, D.B., Namnoum, A.B., Vu, K.V., Van Lingen, B.L., Gray, M.R., McDonough, P.G., Reindollar, R.H. and Jameson, J.L. (1997) Delayed puberty and hypogonadism caused by mutations in the follicle-stimulating hormone -subunit gene. New Engl. J. Med., 337, 607611.
Lockwood, G.M., Muttukrishna, S. and Ledger, W.L. (1998) Inhibins and activins in human ovulation, conception and pregnancy. Hum. Reprod. Update, 4, 284295.
Magoffin, D.A. and Jakimiuk, A.J. (1997) Inhibin A, inhibin B and activin A in the follicular fluid of regularly cycling women. Hum. Reprod., 12, 17141719.[Abstract]
Matthews, C. and Chatterjee, V.K. (1997) Isolated deficiency of follicle-stimulating hormone revisited. New Engl. J. Med., 337, 642.
Matthews, C.H., Borgato, S., Beck-Peccoz, P., Adams, M., Tone, Y., Gambino, G., Casagrande, S., Tedeschini, G., Benedetti, A. and Chatterjee, V.K. (1993) Primary amenorrhea and infertility due to a mutation in the -subunit of follicle-stimulating hormone. Nature Genet., 5, 8386.[ISI][Medline]
Meyer, A.C., Papdimitriou, J.C., Silverberg, S.G. and Sharara, F.I. (2000) Secondary amenorrhea and infertility caused by an inhibin-B-producing ovarian fibrothecoma. Fertil. Steril., 73, 258260.[CrossRef][ISI][Medline]
Petraglia, F., Luisi, S., Pautier, P., Sabourin, J.C., Rey, R., Lhomme, C. and Bidart, J.M. (1998) Inhibin B is the major form of inhibin/activin family secreted by granulosa cell tumors. J. Clin. Endocrinol. Metab., 83, 10291032.
Porestsky, L., Levesque, L., Seibel, M., Smith, D., Pazianos, A., Hurd, J., Aretz, T. and Flier, J. (1988) Characteristics of in vitro steroidogenesis in a woman with hyperandrogenism, a granulosa cell tumor and polycystic ovary disease. J. Reprod. Med., 33, 377381.[ISI][Medline]
Risbridger, G.P., Schmitt, J.F. and Robertson, D.M. (2001) Activins and inhibins in endocrine and ovarian tumors. Endocrinol. Rev., 22, 836858.
Robertson, D.M., Cahir, N., Burger, H.G., Mamers, P. and Groome, N. (1999) Inhibin forms in serum from post-menopausal women with ovarian cancers. Clin. Endocrinol., 50, 381386.[CrossRef][ISI][Medline]
Robertson, D.M., Stephenson, T., Pruysers, E., McCloud, P., Tsigos, A., Groome, N., Mamers, P. and Burger, H.G. (2002) Characterization of inhibin forms and their measurement by an inhibin -subunit ELISA in serum from postmenopausal women with ovarian cancer. J. Clin. Endocrinol. Metab., 87, 816824.
Rossing, M.A., Daling, J.R., Weiss, N.S., Moore, D.E. and Self, S.G. (1994) Ovarian tumors in a cohort of infertile women. N. Eng. J. Med., 331, 771776.
Sakamoto, S., Sakamoto, M., Nagai, A., Obayashi, S., Kubota, T. and Aso, T. (1998) Increased serum level of inhibin causes amenorrhea in a granulosa cell tumor patient. Acta Obstet. Gynecol. Scand., 77, 243244.[ISI][Medline]
Salle, B., de Saint Hilaire, P., Devouassoux, M., Gaucherand, P. and Rudigoz, C. (1997) Another two cases of ovarian tumors in women who had undergone multiple ovulation induction cycles. Hum. Reprod., 12, 17321735.[Abstract]
Soules, M.R., Battaglia, D.E. and Klein, N.A. (1998) Inhibin and reproductive aging in women. Maturitas, 30, 193204.[CrossRef][ISI][Medline]
Tarlatzis, B.C., Grimbizis, G., Bontis, J. and Mantalenakis, S. (1995) Ovarian stimulation and ovarian tumors: a critical reappraisal. Hum. Reprod. Update, 1, 284301.[Abstract]
Unkila-Kallio, L., Tiitinen, A., Wahlstrom, T., Lehtovirta, P. and Leminen, A. (2000) Reproductive features in women developing ovarian granulosa cell tumor at a fertile age. Hum. Reprod., 15, 589593.
Welt, C., Sidis, Y., Keutmann, H. and Schneyer, A. (2002) Activins, inhibins, and follistatins: from endocrinology to signaling. A paradigm for the new millennium. Exp. Biol. Med., 227, 724752.
Willemsen, W., Kruitwagen, R., Bastiaans, B., Hanselaar, T. and Rolland, R. (1993) Ovarian stimulation and granulosa cell tumor. Lancet, 341, 986988.[CrossRef][ISI][Medline]
Submitted on August 7, 2002; accepted on November 26, 2002.